Company News in the Life Science Industry

»

Reset 

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  ASLAN Pharmaceuticals Pte Ltd

Aptinyx to Present Preclinical Data on NYX-458 at the AD/PD 14th International Conference on Alzheimer’s & Parkinson’s Diseases

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Aptinyx Inc.

Tauriga Sciences Inc. Now Shipping its CBD Infused Chewing Gum from its Fulfillment Facility!

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  IBEX Technologies Inc. | Infant Bacterial Therapeutics AB

Sun BioPharma Provides Business Update and Files Annual Report for 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Sun BioPharma, Inc.

Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  DAXOR CORPORATION

Wildflower Brands Featured in CannabisNewsWire Publication Discussing the Farm Bill’s Positive Effect on CBD Sales  

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Better Choice Company Appoints Four New Board of Director Members

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Coherus BioSciences, Inc.

resTORbio, Inc. Announces Closing Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  resTORbio, Inc.

Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Galectin Therapeutics Inc.

The observation status of Oncology Venture is removed

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Assure Holdings Announces Estimated Impact from Fourth Quarter 2018 Increase in Bad Debt Expense

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

2018 Annual Report and Accounts and Notice of AGM 

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Verona Pharma plc

Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019

IBA SA: transparency notification

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  Ion Beam Applications

FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 22 Mar 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies